LabTurbo Biotech (ROCO:7725) LT-Debt-to-Total-Asset: 0.01 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7725 LabTurbo Biotech Corp ROCO:7725
14 GF Score
Price NT$23.00
! 2 Warning Signs
View Full Analysis

What is LabTurbo Biotech LT-Debt-to-Total-Asset?

LabTurbo Biotech ROCO:7725 14 LT-Debt-to-Total-Asset is 0.01 as of Dec. 2025. GuruFocus rates ROCO:7725 with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. LabTurbo Biotech's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.01.

LabTurbo Biotech's long-term debt to total assets ratio declined from Dec. 2024 (0.02) to Dec. 2025 (0.01). It may suggest that LabTurbo Biotech is progressively becoming less dependent on debt to grow their business.

LabTurbo Biotech  (ROCO:7725) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

LabTurbo Biotech LT-Debt-to-Total-Asset Related Terms

LabTurbo Biotech LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for LabTurbo Biotech's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LabTurbo Biotech LT-Debt-to-Total-Asset Chart

LabTurbo Biotech Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
0.03 0.01 0.01 0.02 0.01

LabTurbo Biotech Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only 0.01 0.01 0.02 0.01 0.01
ROCO:7725
14GF Score
LabTurbo Biotech Corp ROCO:7725
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LabTurbo Biotech LT-Debt-to-Total-Asset Calculation

LabTurbo Biotech's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=13.62/1235.389
=0.01

LabTurbo Biotech's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )/Total Assets (Q: Dec. 2025 )
=13.62/1235.389
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.01 mean?
LabTurbo Biotech (ROCO:7725) has a LT-Debt-to-Total-Asset of 0.01 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on LabTurbo Biotech and its competitors.
Is LabTurbo Biotech's LT-Debt-to-Total-Asset too high?
LabTurbo Biotech's current LT-Debt-to-Total-Asset is 0.01. Overall, LabTurbo Biotech has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does LabTurbo Biotech's LT-Debt-to-Total-Asset compare to VRTX and REGN?
LabTurbo Biotech's LT-Debt-to-Total-Asset of 0.01 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on LabTurbo Biotech and its competitors. LabTurbo Biotech's current LT-Debt-to-Total-Asset is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LabTurbo Biotech stock overvalued right now?
LabTurbo Biotech (ROCO:7725) has a current LT-Debt-to-Total-Asset of 0.01. The current LT-Debt-to-Total-Asset is 0.01. LabTurbo Biotech's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For LabTurbo Biotech (ROCO:7725), the current LT-Debt-to-Total-Asset is 0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LabTurbo Biotech Business Description

Address 3F-1, No. 150, Section 4, Chengde Road, Shilin District, Taipei, TWN
LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.
14GF Score

Get the complete analysis for ROCO:7725

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$23.00
Price